Approval · Notice of Compliance 5751 · 1994
CUTIVATE: Notice of Compliance 5751
Issued May 9, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5751
- Date
- May 9, 1994
- Company
- Glaxo Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Topical anti-inflammatory steroid
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CUTIVATE | 02089912 | Cancelled Post Market |
| CUTIVATE | 02090015 | — |
Medicinal ingredients
- FLUTICASONE PROPIONATE 0.05 PER
- FLUTICASONE PROPIONATE 0.005 PER